R Graphics Output - Plos

1000 most variable probesets

leukaemia lymphoma myeloma hematopoietic, disease hematopoietic, cell line other hematopoietic brain endothelium epithelium solid tumor solid, cell line other solid

bone;trans−iliacal bone;menopausia; pulmonary MALT lymphoma; lymph node;diffuse large B−cell lymphoma; diffuse large B−cell lymphoma; lymph node;chronic Hodgkin's lymphoma; lymph node;diffuse large B−cell lymphoma;patient treated; peripheral T−cell lymphoma; cell line;Sez−4;T−cell lymphoma;treated; plasma cell;multiple myeloma; bone marrow;multiple myeloma; bone marrow;plasma cell;multiple myeloma; bone marrow;plasma cell;myeloma; cell line;U937;diffuse histiocytic lymphoma;treated; cell line;THP−1;acute monocytic leukaemia;treated; cell line;THP−1;acute monocytic leukaemia; macrophage;treated; dendritic cell;monocyte derived;treated; alveolar macrophage; alveolar macrophage;smoking; dendritic cell;monocyte derived; dendritic cell;Newcastle disease virus infection; macrophage;monocyte derived;treated; B−cell; cell line;EREB2−5;B−lymphoblastoid;treated; cell line;lymphoblast;retinitis pigmentosa; cell line;lymphoblastoid;asthma; cell line;lymphoblastoid; mononuclear cell;leukaemia;CML; T−ALL cell;leukaemia; pediatric T−ALL; leukemic lymphoblast;common ALL; bone marrow or peripheral blood;leukaemia;ALL; bone marrow;leukaemia;ALL; blast;precursor B−cell acute lymphoblastic leukaemia; bone marrow;leukaemia;ALL;hyperdiploid karyotype; bone marrow;leukaemia;Pre−B−ALL;c−ALL; bone marrow;leukaemia;Pro−B−ALL;MLL; bone marrow;white blood cell;pediatric acute leukaemia; bone marrow;leukaemia;c−ALL;Pre−B−ALL; bone marrow;leukaemia;childhood B−cell precursor ALL; white blood cell;leukaemia;ALL; synovial fluid mononuclear cell;oligoarticular juvenile idiopathic arthritis; monocyte;treated; dendritic cell;monocyte derived;cultured; bone marrow;leukaemia;CLL; peripheral blood;T−cell; peripheral blood;T−cell;leukaemia;AML; T−cell; lymphocyte;leukaemia;CLL; peripheral blood mononuclear cell;leukaemia;CLL; peripheral blood;leukaemia;CLL; leukaemia;CLL; bone marrow;leukaemia;T−ALL; bone marrow;promyelocyte;leukaemia;AML; bone marrow; peripheral blood mononuclear cell;leukaemia;AML;FAB−M0; blasts and mononuclear cells;leukaemia;AML; bone marrow or peripheral blood;leukaemia;AML; bone marrow;mononuclear cell;leukaemia;AML; bone marrow;leukaemia;AML;MLL; mononuclear cell;leukaemia;AML;NPM1 mutated; bone marrow;leukaemia;AML;other abnormalities; bone marrow;leukaemia;AML; peripheral blood mononuclear cell;leukaemia;AML;multilineage dysplasia; mononuclear cell;leukaemia;AML; bone marrow;leukaemia;AML;aberrant karyotype; polymorphonuclear leukocyte;cultured; bone marrow;precursor B−cell; bone marrow;juvenile myelomonocytic leukaemia; bone marrow;leukaemia;CML; bone marrow;myelodysplastic syndrome; peripheral blood mononuclear cell;treated; monocyte; peripheral blood monocyte; peripheral blood mononuclear cell;cultured; peripheral blood;treated; peripheral blood; mononuclear cell; mononuclear cell;acute graft−versus−host disease; peripheral blood mononuclear cell;multiple sclerosis or clinically isolated syndrome; peripheral blood mononuclear cell;multiple sclerosis or clinically isolated syndrome;patient treated; peripheral blood mononuclear cell; peripheral blood;malaria vaccine; whole blood;autism spectrum disorder; peripheral blood;fasted patient; peripheral blood mononuclear cell;kidney transplant recipient;patient treated; neutrophil; whole blood;obesity; peripheral blood leukocyte; whole blood; blood;patient on diet; blood; peripheral blood mononuclear cell;sepsis; peripheral blood mononuclear cell;systemic inflammatory response syndrome; whole blood leukocyte; buffy coat;risk for VAP; peripheral blood;burnt patient;inhalation injury; peripheral blood;burnt patient; blood;kidney transplant recipient;patient treated; peripheral blood;chronic allograft nephropathy;patient treated; peripheral blood;whole blood; umbilical cord blood;arsenic exposed mother; whole blood;sepsis; whole blood;septic shock; peripheral blood;septic shock; cell line;HEK−293;embryonic kidney cell;transfected; cell line;HEK−293T;embryonic kidney cell;transfected; hESC;human embryonic stem cell; cell line;U2−OS;osteosarcoma;transfected; cell line;U251;glioblastoma;treated; cell line;SH−SY5Y−E;neuroblastoma;treated; cell line;SH−SY5Y−A;neuroblastoma;treated; cell line;H295R;adrenocortical carcinoma;treated; cell line;A2780;ovarian adenocarcinoma; cell line;A2780;ovarian adenocarcinoma;treated; ovary;serous epithelial ovarian cancer;treated; cell line;SK−N−SH;neuroblastoma;treated; cell line;ARPE−19;retinal pigment epithelium;treated; aortic endothelial cells; huvec; huvec;treated; bone marrow;mesenchymal stem cell; fibroblast;skin fibroblast; smooth muscle cell;treated; synovial membrane;rheumatoid arthritis;treated; synovial membrane;osteoarthritis;treated; stem cell;adipose derived; bone marrow;mesenchymal stem cell;treated; bone;osteoblast;treated; skin;keratinocyte;stimulated; neonatal foreskin;cultured epidermis; skin;epidermal keratinocyte;treated; cell line;HT−29;colorectal adenocarcinoma; bronchial epithelial cell;cultured; cell line;hBEC;bronchial epithelial cell; cell line;hBEC;bronchial epithelial cell;smoke exposed; cell line;LNCaP;prostate adenocarcinoma;treated; cell line;MCF−7;breast cancer; cell line;MCF−7;breast cancer;transfected; cell line;MCF−7;breast cancer;transfected;treated; cell line;MCF−7;breast cancer;treated; cell line;HepaRG;hepatoma;treated; liver;hepatocyte;treated; cell line;Huh7;hepatocellular carcinoma;treated; cell line;Huh7;hepatocellular carcinoma; cell line;HepG2;hepatocellular carcinoma; cell line;HepG2;hepatocellular carcinoma;treated; cell line;HepG2;hepatocellular carcinoma;transfected; bronchial epithelial cell;exposed to smoke; bronchial epithelial cell; airway epithelial cell;treated; cell line;MCF−10A;mammary epithelial cell; cell line;MSK−Leuk1;oral epithelium; cell line;HCT−116;colorectal cancer;treated; cell line;HCT−116;colorectal cancer;transfected; cell line;HCT−116;colorectal cancer; cell line;Ishikawa;endometrial adenocarcinoma;treated; cell line;MCF−10A;mammary epithelial cell;transfected; bronchial epithelial cell;transfected; cell line;HT1080;fibrosarcoma;treated; cell line;A375;melanoma;treated; cell line;MDA−MB−231;breast cancer;transfected; cell line;MDA−MB−231;breast cancer;treated; cell line;MDA−MB−231;breast cancer; cell line;A549;lung adenocarcinoma;infected; cell line;DU145;prostatic cancer;treated; cell line;A549;lung adenocarcinoma;transfected; cell line;A549;lung adenocarcinoma; cell line;A549;lung adenocarcinoma;treated; cell line;HK2;renal proximal tubular cell;treated; cell line;BEAS−2B;bronchiole epithelial cell; cell line;BEAS−2B;bronchiole epithelial cell;treated; cell line;HeLa;cervical carcinoma; cell line;HeLa;cervical carcinoma;transfected; cell line;HeLa;cervical carcinoma;transfected;treated; cell line;HeLa;cervical carcinoma;treated; cell line;RPMI−8226;multiple myeloma; cell line;RPMI−8226;multiple myeloma;transfected; colorectal carcinoma;cultured; nasal epithelium;rhinovirus; nasal epithelium; airway epithelial cell; airway epithelial cell;COPD; colon;ulcerative colitis;patient treated; nasopharyngeal carcinoma; colon;adenocarcinoma; colorectal adenoma; colonic mucosa;ulcerative colitis; intestine;ileum;Crohn's disease; colonic mucosa;ulcerative colitis;patient treated; colorectal adenocarcinoma; colon;carcinoma; colorectal carcinoma; colorectal tissue; colon; colonic mucosa; gastric tissue;adjacent to tumour; colon;sigmoid colon;irritable bowel syndrome; colon;sigmoid colon mucosa; liver;biliary atresia; liver; liver;hepatocellular carcinoma;HCV; pancreas;pancreatic tumor;adjacent tissue; kidney;allograft;rejection; kidney;clear−cell renal cell carcinoma;metastatic; lung;non−small cell adenocarcinoma patient;normal tissue; lung;lung cancer;adjacent tissue; lung; skin;psoriasis; gingival papillae;periodontitis;unaffected site; gingival papillae;periodontitis; cervix;cervical cancer; hypopharynx;head and neck squamous cell carcinoma; breast;basal−like breast cancer; breast;ductal carcinoma; breast;mammary gland;invasive ductal carcinoma; breast tumor;non−basal like breast cancer; gastric tumor; pancreatic tumor; lung cancer;NSCLC; lung cancer; lung;adenocarcinoma; fetal lung; skin;psoriasis;non lesional skin; skin; umbilical cord; uterus;leiomyoma; uterus;myometrium;uterine fibroid; uterus;myometrium;leiomyoma; uterus;myometrium; uterus;endometrium;prolapse;patient treated; uterus;endometrium; ovarian cancer; ovarian carcinoma; kidney;allograft;IFTA; kidney;allograft; prostate tumor; prostate; prostate;high−grade prostatic intraepithelial neoplasia;diet; prostate;benign prostatic hyperplasia; skin;melanoma; extremity melanoma;patient treated; placenta; bone;Ewing's sarcoma;bone tumor; brain;meningioma; breast; breast;breast duct; breast;lobular carcinoma; breast tumor; breast tumor;patient treated; breast;invasive ductal carcinoma; brain;glioblastoma multiforme;patient treated; brain;diffuse glioma; brain;medulloblastoma; brain;ependymoma; PNS;neuroblastoma; brain;pilocytic astrocytoma; brain;glioblastoma; brain;glioblastoma;patient treated; brain;substantia nigra; brain; brain;schizophrenia; brain;dorsolateral prefrontal cortex; brain;prefrontal cortex; brain;prefrontal cortex;schizophrenia; brain;postcentral gyrus; brain;superior frontal gyrus; brain;entorhinal cortex; brain;hippocampus; metastatic melanoma; adrenal gland;adenoma; gastrointestinal stromal tumor; internal trunk;liposarcoma; extremity;leiomyosarcoma; extremity;undifferentiated sarcoma; trunk wall;undifferentiated sarcoma; fat;subcutaneous adipose tissue; heart;dilated cardiomyopathy; skeletal muscle;biceps; skeletal muscle;vastus lateralis; skeletal muscle; fat;abdominal fat; fat;abdominal fat;obesity; fat;gluteal fat;obesity; fat;adipose tissue; fat;gluteal fat; fat;adipose tissue;obesity;

fat;adipose tissue;obesity; fat;gluteal fat; fat;adipose tissue; fat;gluteal fat;obesity; fat;abdominal fat;obesity; fat;abdominal fat; skeletal muscle; skeletal muscle;vastus lateralis; skeletal muscle;biceps; heart;dilated cardiomyopathy; fat;subcutaneous adipose tissue; trunk wall;undifferentiated sarcoma; extremity;undifferentiated sarcoma; extremity;leiomyosarcoma; internal trunk;liposarcoma; gastrointestinal stromal tumor; adrenal gland;adenoma; metastatic melanoma; brain;hippocampus; brain;entorhinal cortex; brain;superior frontal gyrus; brain;postcentral gyrus; brain;prefrontal cortex;schizophrenia; brain;prefrontal cortex; brain;dorsolateral prefrontal cortex; brain;schizophrenia; brain; brain;substantia nigra; brain;glioblastoma;patient treated; brain;glioblastoma; brain;pilocytic astrocytoma; PNS;neuroblastoma; brain;ependymoma; brain;medulloblastoma; brain;diffuse glioma; brain;glioblastoma multiforme;patient treated; breast;invasive ductal carcinoma; breast tumor;patient treated; breast tumor; breast;lobular carcinoma; breast;breast duct; breast; brain;meningioma; bone;Ewing's sarcoma;bone tumor; placenta; extremity melanoma;patient treated; skin;melanoma; prostate;benign prostatic hyperplasia; prostate;high−grade prostatic intraepithelial neoplasia;diet; prostate; prostate tumor; kidney;allograft; kidney;allograft;IFTA; ovarian carcinoma; ovarian cancer; uterus;endometrium; uterus;endometrium;prolapse;patient treated; uterus;myometrium; uterus;myometrium;leiomyoma; uterus;myometrium;uterine fibroid; uterus;leiomyoma; umbilical cord; skin; skin;psoriasis;non lesional skin; fetal lung; lung;adenocarcinoma; lung cancer; lung cancer;NSCLC; pancreatic tumor; gastric tumor; breast tumor;non−basal like breast cancer; breast;mammary gland;invasive ductal carcinoma; breast;ductal carcinoma; breast;basal−like breast cancer; hypopharynx;head and neck squamous cell carcinoma; cervix;cervical cancer; gingival papillae;periodontitis; gingival papillae;periodontitis;unaffected site; skin;psoriasis; lung; lung;lung cancer;adjacent tissue; lung;non−small cell adenocarcinoma patient;normal tissue; kidney;clear−cell renal cell carcinoma;metastatic; kidney;allograft;rejection; pancreas;pancreatic tumor;adjacent tissue; liver;hepatocellular carcinoma;HCV; liver; liver;biliary atresia; colon;sigmoid colon mucosa; colon;sigmoid colon;irritable bowel syndrome; gastric tissue;adjacent to tumour; colonic mucosa; colon; colorectal tissue; colorectal carcinoma; colon;carcinoma; colorectal adenocarcinoma; colonic mucosa;ulcerative colitis;patient treated; intestine;ileum;Crohn's disease; colonic mucosa;ulcerative colitis; colorectal adenoma; colon;adenocarcinoma; nasopharyngeal carcinoma; colon;ulcerative colitis;patient treated; airway epithelial cell;COPD; airway epithelial cell; nasal epithelium; nasal epithelium;rhinovirus; colorectal carcinoma;cultured; cell line;RPMI−8226;multiple myeloma;transfected; cell line;RPMI−8226;multiple myeloma; cell line;HeLa;cervical carcinoma;treated; cell line;HeLa;cervical carcinoma;transfected;treated; cell line;HeLa;cervical carcinoma;transfected; cell line;HeLa;cervical carcinoma; cell line;BEAS−2B;bronchiole epithelial cell;treated; cell line;BEAS−2B;bronchiole epithelial cell; cell line;HK2;renal proximal tubular cell;treated; cell line;A549;lung adenocarcinoma;treated; cell line;A549;lung adenocarcinoma; cell line;A549;lung adenocarcinoma;transfected; cell line;DU145;prostatic cancer;treated; cell line;A549;lung adenocarcinoma;infected; cell line;MDA−MB−231;breast cancer; cell line;MDA−MB−231;breast cancer;treated; cell line;MDA−MB−231;breast cancer;transfected; cell line;A375;melanoma;treated; cell line;HT1080;fibrosarcoma;treated; bronchial epithelial cell;transfected; cell line;MCF−10A;mammary epithelial cell;transfected; cell line;Ishikawa;endometrial adenocarcinoma;treated; cell line;HCT−116;colorectal cancer; cell line;HCT−116;colorectal cancer;transfected; cell line;HCT−116;colorectal cancer;treated; cell line;MSK−Leuk1;oral epithelium; cell line;MCF−10A;mammary epithelial cell; airway epithelial cell;treated; bronchial epithelial cell; bronchial epithelial cell;exposed to smoke; cell line;HepG2;hepatocellular carcinoma;transfected; cell line;HepG2;hepatocellular carcinoma;treated; cell line;HepG2;hepatocellular carcinoma; cell line;Huh7;hepatocellular carcinoma; cell line;Huh7;hepatocellular carcinoma;treated; liver;hepatocyte;treated; cell line;HepaRG;hepatoma;treated; cell line;MCF−7;breast cancer;treated; cell line;MCF−7;breast cancer;transfected;treated; cell line;MCF−7;breast cancer;transfected; cell line;MCF−7;breast cancer; cell line;LNCaP;prostate adenocarcinoma;treated; cell line;hBEC;bronchial epithelial cell;smoke exposed; cell line;hBEC;bronchial epithelial cell; bronchial epithelial cell;cultured; cell line;HT−29;colorectal adenocarcinoma; skin;epidermal keratinocyte;treated; neonatal foreskin;cultured epidermis; skin;keratinocyte;stimulated; bone;osteoblast;treated; bone marrow;mesenchymal stem cell;treated; stem cell;adipose derived; synovial membrane;osteoarthritis;treated; synovial membrane;rheumatoid arthritis;treated; smooth muscle cell;treated; fibroblast;skin fibroblast; bone marrow;mesenchymal stem cell; huvec;treated; huvec; aortic endothelial cells; cell line;ARPE−19;retinal pigment epithelium;treated; cell line;SK−N−SH;neuroblastoma;treated; ovary;serous epithelial ovarian cancer;treated; cell line;A2780;ovarian adenocarcinoma;treated; cell line;A2780;ovarian adenocarcinoma; cell line;H295R;adrenocortical carcinoma;treated; cell line;SH−SY5Y−A;neuroblastoma;treated; cell line;SH−SY5Y−E;neuroblastoma;treated; cell line;U251;glioblastoma;treated; cell line;U2−OS;osteosarcoma;transfected; hESC;human embryonic stem cell; cell line;HEK−293T;embryonic kidney cell;transfected; cell line;HEK−293;embryonic kidney cell;transfected; peripheral blood;septic shock; whole blood;septic shock; whole blood;sepsis; umbilical cord blood;arsenic exposed mother; peripheral blood;whole blood; peripheral blood;chronic allograft nephropathy;patient treated; blood;kidney transplant recipient;patient treated; peripheral blood;burnt patient; peripheral blood;burnt patient;inhalation injury; buffy coat;risk for VAP; whole blood leukocyte; peripheral blood mononuclear cell;systemic inflammatory response syndrome; peripheral blood mononuclear cell;sepsis; blood; blood;patient on diet; whole blood; peripheral blood leukocyte; whole blood;obesity; neutrophil; peripheral blood mononuclear cell;kidney transplant recipient;patient treated; peripheral blood;fasted patient; whole blood;autism spectrum disorder; peripheral blood;malaria vaccine; peripheral blood mononuclear cell; peripheral blood mononuclear cell;multiple sclerosis or clinically isolated syndrome;patient treated; peripheral blood mononuclear cell;multiple sclerosis or clinically isolated syndrome; mononuclear cell;acute graft−versus−host disease; mononuclear cell; peripheral blood; peripheral blood;treated; peripheral blood mononuclear cell;cultured; peripheral blood monocyte; monocyte; peripheral blood mononuclear cell;treated; bone marrow;myelodysplastic syndrome; bone marrow;leukaemia;CML; bone marrow;juvenile myelomonocytic leukaemia; bone marrow;precursor B−cell; polymorphonuclear leukocyte;cultured; bone marrow;leukaemia;AML;aberrant karyotype; mononuclear cell;leukaemia;AML; peripheral blood mononuclear cell;leukaemia;AML;multilineage dysplasia; bone marrow;leukaemia;AML; bone marrow;leukaemia;AML;other abnormalities; mononuclear cell;leukaemia;AML;NPM1 mutated; bone marrow;leukaemia;AML;MLL; bone marrow;mononuclear cell;leukaemia;AML; bone marrow or peripheral blood;leukaemia;AML; blasts and mononuclear cells;leukaemia;AML; peripheral blood mononuclear cell;leukaemia;AML;FAB−M0; bone marrow; bone marrow;promyelocyte;leukaemia;AML; bone marrow;leukaemia;T−ALL; leukaemia;CLL; peripheral blood;leukaemia;CLL; peripheral blood mononuclear cell;leukaemia;CLL; lymphocyte;leukaemia;CLL; T−cell; peripheral blood;T−cell;leukaemia;AML; peripheral blood;T−cell; bone marrow;leukaemia;CLL; dendritic cell;monocyte derived;cultured; monocyte;treated; synovial fluid mononuclear cell;oligoarticular juvenile idiopathic arthritis; white blood cell;leukaemia;ALL; bone marrow;leukaemia;childhood B−cell precursor ALL; bone marrow;leukaemia;c−ALL;Pre−B−ALL; bone marrow;white blood cell;pediatric acute leukaemia; bone marrow;leukaemia;Pro−B−ALL;MLL; bone marrow;leukaemia;Pre−B−ALL;c−ALL; bone marrow;leukaemia;ALL;hyperdiploid karyotype; blast;precursor B−cell acute lymphoblastic leukaemia; bone marrow;leukaemia;ALL; bone marrow or peripheral blood;leukaemia;ALL; leukemic lymphoblast;common ALL; pediatric T−ALL; T−ALL cell;leukaemia; mononuclear cell;leukaemia;CML; cell line;lymphoblastoid; cell line;lymphoblastoid;asthma; cell line;lymphoblast;retinitis pigmentosa; cell line;EREB2−5;B−lymphoblastoid;treated; B−cell; macrophage;monocyte derived;treated; dendritic cell;Newcastle disease virus infection; dendritic cell;monocyte derived; alveolar macrophage;smoking; alveolar macrophage; dendritic cell;monocyte derived;treated; macrophage;treated; cell line;THP−1;acute monocytic leukaemia; cell line;THP−1;acute monocytic leukaemia;treated; cell line;U937;diffuse histiocytic lymphoma;treated; bone marrow;plasma cell;myeloma; bone marrow;plasma cell;multiple myeloma; bone marrow;multiple myeloma; plasma cell;multiple myeloma; cell line;Sez−4;T−cell lymphoma;treated; peripheral T−cell lymphoma; lymph node;diffuse large B−cell lymphoma;patient treated; lymph node;chronic Hodgkin's lymphoma; diffuse large B−cell lymphoma; lymph node;diffuse large B−cell lymphoma; pulmonary MALT lymphoma; bone;trans−iliacal bone;menopausia;